What is Relay Therapeutics, Inc.'s PP&E (net)?

Relay Therapeutics, Inc. (RLAY) reported PP&E (net) of $1.22M in Q1 2026.

How has Relay Therapeutics, Inc.'s PP&E (net) changed year-over-year?

Relay Therapeutics, Inc.'s PP&E (net) decreased by 76.3% year-over-year, from $5.15M to $1.22M.

What is the long-term trend for Relay Therapeutics, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s PP&E (net) has grown at a -22.7% compound annual growth rate (CAGR), from $6.25M to $1.73M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Relay Therapeutics, Inc. RLAY PP&E (Net)

PP&E (Net) at other companies

CelcuityCELC

$619K+72.9%

Revolution Medicines, Inc.RVMD

$31.48M+15.9%

Ligand PharmaceuticalsLGND

$3.44M-4.9%

Cogent Biosciences, Inc.COGT

$5.3M-17.9%

Tango TherapeuticsTNGX

$6.38M-15.4%

LQD

Liquidia CorporationLQDA

$20.84M+146%

Other financials

Income statement

See full

Revenue$3.0M-60.9%

Operating income-$78.6M+7.4%

Net income-$73.3M+4.9%

EPS (diluted)-$0.41+10.9%

Balance sheet

See full

Cash & equivalents$204.6M+119%

Total debt$31.6M-33.1%

Total equity$642.2M-10.9%

Total assets$699.6M-12.5%

Cash flow

See full

Operating cash flow-$51.1M+30.2%

CapEx$1.0K—

Free cash flow-$44.9M+22.5%

Valuation

See full

Market cap$3.46B+300%

Enterprise value$3.29B+304%

P/S324.1×+212×

Profitability

See full

Operating margin-2,776.6%-820pp

Net margin-2,554.1%-745pp

FCF margin-1,536%-429pp

Returns & leverage

See full

Return on equity-40%-4.3pp

Debt / equity0×0.0×

Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s PP&E (net)?: Relay Therapeutics, Inc. (RLAY) reported PP&E (net) of $1.22M in Q1 2026.
How has Relay Therapeutics, Inc.'s PP&E (net) changed year-over-year?: Relay Therapeutics, Inc.'s PP&E (net) decreased by 76.3% year-over-year, from $5.15M to $1.22M.
What is the long-term trend for Relay Therapeutics, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s PP&E (net) has grown at a -22.7% compound annual growth rate (CAGR), from $6.25M to $1.73M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.